{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:04:30Z","timestamp":1777982670916,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Foundation of Tianjin Union Medical Center"},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin","doi-asserted-by":"crossref","award":["24JCZDJC01350"],"award-info":[{"award-number":["24JCZDJC01350"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01402-4","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:49:18Z","timestamp":1772095758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of Lymphocyte Subsets in Peripheral Blood of Patients with Colorectal Cancer"],"prefix":"10.1007","volume":"57","author":[{"given":"Guanghai","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-1652","authenticated-orcid":false,"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"2","key":"1402_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1402_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"3","key":"1402_CR3","first-page":"177","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177\u201393.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1402_CR4","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1402_CR5","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/ijc.33056","volume":"147","author":"MF Tolba","year":"2020","unstructured":"Tolba MF. Revolutionizing the landscape of colorectal cancer treatment: the potential role of immune checkpoint inhibitors. Int J Cancer. 2020;147(11):2996\u20133006.","journal-title":"Int J Cancer"},{"issue":"12","key":"1402_CR6","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"SK Kumar","year":"2020","unstructured":"Kumar SK, Callander NS, Adekola K, et al. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(12):1685\u2013717.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"1402_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(3):329\u201359.","journal-title":"J Natl Compr Canc Netw"},{"key":"1402_CR8","doi-asserted-by":"crossref","unstructured":"Pardini B, Ferrero G, Tarallo S, et al. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study. Gastroenterology. 2023;165(3):582\u2013599.e8.","DOI":"10.1053\/j.gastro.2023.05.037"},{"issue":"6","key":"1402_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41419-023-05881-2","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Luo J, Yang W, Ye WC. CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets. Cell Death Dis. 2023;14(6):353.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"18166","DOI":"10.1038\/s41598-022-23190-0","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Chen X, Zu S, Lu Y. Characteristics of circulating adaptive immune cells in patients with colorectal cancer. Sci Rep. 2022;12(1):18166.","journal-title":"Sci Rep"},{"key":"1402_CR11","doi-asserted-by":"crossref","unstructured":"Lu C, Schardey J, Wirth U, et al. Analysis of Circulating Immune Subsets in Primary Colorectal Cancer. Cancers (Basel). 2022;12;14(24):6105.","DOI":"10.3390\/cancers14246105"},{"issue":"6","key":"1402_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1402_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/nyas.13625","volume":"1417","author":"K Shitara","year":"2018","unstructured":"Shitara K, Nishikawa H. Regulatory T cells: a potential target in cancer immunotherapy. Ann N Y Acad Sci. 2018;1417(1):104\u201315.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1402_CR14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-019-02343-7","volume":"68","author":"D Krijgsman","year":"2019","unstructured":"Krijgsman D, de Vries NL, Skovbo A, et al. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer Immunol Immunother. 2019;68(6):1011\u201324.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1402_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/jgh.15774","volume":"37","author":"HY Jin","year":"2022","unstructured":"Jin HY, Yoo SY, Lee JA, et al. Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers. J Gastroenterol Hepatol. 2022;37(3):551\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1402_CR16","doi-asserted-by":"publisher","first-page":"9493","DOI":"10.1038\/s41598-023-36200-6","volume":"13","author":"J Kim","year":"2023","unstructured":"Kim J, Phan MT, Hwang I, Park J, Cho D. Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells. Sci Rep. 2023;13(1):9493.","journal-title":"Sci Rep"},{"key":"1402_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejca.2020.08.024","volume":"140","author":"D Malka","year":"2020","unstructured":"Malka D, Lievre A, Andre T, Taieb J, Ducreux M, Bibeau F. Immune scores in colorectal cancer: where are we? Eur J Cancer. 2020;140:105\u201318.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41416-021-01586-5","volume":"126","author":"K Aasebo","year":"2022","unstructured":"Aasebo K, Bruun J, Bergsland CH, et al. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. Br J Cancer. 2022;126(1):48\u201356.","journal-title":"Br J Cancer"},{"key":"1402_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1102545","volume":"10","author":"C Yuan","year":"2023","unstructured":"Yuan C, Huang J, Li H, et al. Association of clinical outcomes and the predictive value of T lymphocyte subsets within colorectal cancer patients. Front Surg. 2023;10:1102545.","journal-title":"Front Surg"},{"key":"1402_CR20","doi-asserted-by":"crossref","unstructured":"Tada N, Kawai K, Tsuno NH, et al. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets. World J Surg Oncol. 2015;13:30.","DOI":"10.1186\/s12957-014-0418-0"},{"key":"1402_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"E Picard","year":"2020","unstructured":"Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol. 2020;11:369.","journal-title":"Front Immunol"},{"issue":"1","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1186\/s12885-022-09438-y","volume":"22","author":"J Zhu","year":"2022","unstructured":"Zhu J, Fang R, Pan Z, Qian X. Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma. BMC Cancer. 2022;22(1):716.","journal-title":"BMC Cancer"},{"issue":"6","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2007.10.012","volume":"27","author":"C Stemberger","year":"2007","unstructured":"Stemberger C, Huster KM, Koffler M, et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity. 2007;27(6):985\u201397.","journal-title":"Immunity"},{"issue":"11","key":"1402_CR24","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","volume":"101","author":"J Geginat","year":"2003","unstructured":"Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 2003;101(11):4260\u20136.","journal-title":"Blood"},{"key":"1402_CR25","doi-asserted-by":"crossref","unstructured":"Zander R, Schauder D, Xin G, et al. CD4(+) T Cell Help Is Required for the Formation of a Cytolytic CD8(+) T Cell Subset that Protects against Chronic Infection and Cancer. Immunity. 2019;51(6):1028\u20131042 e1024.","DOI":"10.1016\/j.immuni.2019.10.009"},{"issue":"1","key":"1402_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01371-x","volume":"22","author":"SV Fernandez","year":"2020","unstructured":"Fernandez SV, MacFarlane AWt, Jillab M, et al. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Res. 2020;22(1):134.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1402_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4174\/astr.2018.94.6.312","volume":"94","author":"J Choi","year":"2018","unstructured":"Choi J, Maeng HG, Lee SJ, et al. Diagnostic value of peripheral blood immune profiling in colorectal cancer. Ann Surg Treat Res. 2018;94(6):312\u201321.","journal-title":"Ann Surg Treat Res"},{"issue":"11","key":"1402_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","volume":"21","author":"M Reina-Campos","year":"2021","unstructured":"Reina-Campos M, Scharping NE, Goldrath AW. CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21(11):718\u201338.","journal-title":"Nat Rev Immunol"},{"key":"1402_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715234","volume":"12","author":"JS Dolina","year":"2021","unstructured":"Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S. CD8(+) T cell exhaustion in cancer. Front Immunol. 2021;12:715234.","journal-title":"Front Immunol"},{"key":"1402_CR30","doi-asserted-by":"publisher","first-page":"102860","DOI":"10.1016\/j.ebiom.2020.102860","volume":"57","author":"K Fujiyoshi","year":"2020","unstructured":"Fujiyoshi K, Vayrynen JP, Borowsky J, et al. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer. EBioMedicine. 2020;57:102860.","journal-title":"EBioMedicine"},{"issue":"1","key":"1402_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10576-0","volume":"23","author":"M Jung","year":"2023","unstructured":"Jung M, Rose M, Knuechel R, et al. Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer. BMC Cancer. 2023;23(1):113.","journal-title":"BMC Cancer"},{"issue":"8","key":"1402_CR32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00262-021-03127-8","volume":"71","author":"J Waidhauser","year":"2022","unstructured":"Waidhauser J, Nerlinger P, Arndt TT, et al. Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma. Cancer Immunol Immunother. 2022;71(8):1937\u201347.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"1402_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/08820139.2018.1480030","volume":"47","author":"J Spacek","year":"2018","unstructured":"Spacek J, Vocka M, Netikova I, et al. Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls. Immunol Invest. 2018;47(7):643\u201353.","journal-title":"Immunol Invest"},{"issue":"2","key":"1402_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/jcmm.14037","volume":"23","author":"X Jia","year":"2019","unstructured":"Jia X, Liu H, Xu C, et al. MiR-15a\/16-1 deficiency induces IL-10-producing CD19(+) TIM-1(+) cells in tumor microenvironment. J Cell Mol Med. 2019;23(2):1343\u201353.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"1402_CR35","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/2211-5463.13005","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Niu N, Sun J, Mou Y, He X, Mei L. IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1. FEBS Open Bio. 2020;10(12):2687\u2013701.","journal-title":"FEBS Open Bio"},{"key":"1402_CR36","first-page":"73","volume":"6","author":"I Langers","year":"2012","unstructured":"Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N. Natural killer cells: role in local tumor growth and metastasis. Biologics. 2012;6:73\u201382.","journal-title":"Biologics"},{"issue":"4","key":"1402_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pan.2014.05.797","volume":"14","author":"YF Xu","year":"2014","unstructured":"Xu YF, Lu Y, Cheng H, et al. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival. Pancreatology. 2014;14(4):295\u2013301.","journal-title":"Pancreatology"},{"issue":"9","key":"1402_CR38","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1158\/2159-8290.CD-24-1232","volume":"15","author":"NJ Song","year":"2025","unstructured":"Song NJ, Xie J, Jung KJ, et al. Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers. Cancer Discov. 2025;15(9):1835\u201357.","journal-title":"Cancer Discov"},{"issue":"9","key":"1402_CR39","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/2159-8290.CD-24-1208","volume":"15","author":"J Pozniak","year":"2025","unstructured":"Pozniak J, Roda N, Landeloos E, et al. Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype. Cancer Discov. 2025;15(9):1819\u201334.","journal-title":"Cancer Discov"},{"issue":"747","key":"1402_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2952","volume":"16","author":"SY Neo","year":"2024","unstructured":"Neo SY, Tong L, Chong J, et al. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis. Sci Transl Med. 2024;16(747):eadi2952.","journal-title":"Sci Transl Med"},{"issue":"95","key":"1402_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj7970","volume":"9","author":"M Kilian","year":"2024","unstructured":"Kilian M, Friedrich MJ, Lu KH, et al. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance. Sci Immunol. 2024;9(95):eadj7970.","journal-title":"Sci Immunol"},{"issue":"9","key":"1402_CR42","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/2159-8290.CD-25-1042","volume":"15","author":"F Galvez-Cancino","year":"2025","unstructured":"Galvez-Cancino F, Armero M, Withers DR, et al. The Dark Side of NK Cells in Cancer Immunotherapy. Cancer Discov. 2025;15(9):1777\u20139.","journal-title":"Cancer Discov"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01402-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01402-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01402-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:49:21Z","timestamp":1772095761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01402-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01402-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7672745\/v1","asserted-by":"object"}]},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere, and there is no conflict of interests. All authors have approved the manuscript for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"53"}}